Evidence map›Paper›PMID 41063068›Full record

ArticleBMC public health2025

Vaccination models of delivery for refugees and migrants: a global scoping review.

Fariba Aghajafari, Dorota Guzek, Huzaifa Kamal, Alyssa Ness, Laurent Wall, Caitlin McClurg, Arshya Pooladi-Darvish, Amanda M Weightman, Annalee Coakley

Abstract readScoping Review
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fariba AghajafariDepartment of Family Medicine, University of Calgary, Calgary, AB, Canada. Fariba.aghajafari@ucalgary.ca.
Dorota GuzekHabitus Consulting Collective Inc., Calgary, AB, Canada.
Huzaifa KamalHealth Sciences, University of Calgary, Calgary, AB, Canada.
Alyssa NessDepartment of Family Medicine, University of Calgary, Calgary, AB, Canada.
Laurent WallHabitus Consulting Collective Inc., Calgary, AB, Canada.
Caitlin McClurgLibraries & Cultural Resources, University of Calgary, Calgary, AB, Canada.
Arshya Pooladi-DarvishDepartment of Medical Biophysics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.
Amanda M WeightmanHabitus Consulting Collective Inc., Calgary, AB, Canada.
Annalee CoakleyDepartment of Family Medicine, University of Calgary, Calgary, AB, Canada.

Funding

College of Family Physicians of Canada CoRIG II
6 · The paper itself

Abstract

backgroundRefugees and migrants face inequities in healthcare and vaccination access. Diverse vaccination programs have been implemented globally among refugee and migrant populations targeting vaccine hesitancy and other barriers to vaccination. The aim of this scoping review was to provide an overview of current models of vaccination delivery of COVID-19 and other vaccines to inform best practices of vaccine delivery for refugee and migrant populations.

methodsA scoping review was conducted according to PRISMA guidelines. Eleven electronic databases, including SCOPUS, Embase, Medline, and Web of Science, as well as grey literature, were searched with keywords including: 'COVID-19', 'vaccines','immunizations', 'refugees', 'asylum seekers', and 'migrants'. The search included all studies published between January 2000 and October 2023 to capture COVID-19 and other vaccine models of delivery. The main outcome was models of delivery of COVID-19 vaccines and other vaccines for refugee or migrant populations. Models of vaccination delivery were reviewed and analyzed with the 2022 World Health Organization's Strengthening COVID-19 vaccine demand and uptake in refugees and migrants: An operational guide (2022 WHO Guide) as a guiding framework.

resultsA total of n = 11,825 unique studies were identified through database searches. Thirty-three (n = 33) studies were included in this review. Fifteen studies (n = 15) related to the COVID-19 vaccine and eighteen studies (n = 18) focused on other vaccines. Studies were mainly implemented in high-income countries with the majority from the United States (n = 17). Studies targeted various migrant groupings (i.e., migrants, immigrants, refugees, and asylum-seekers), ethnic groups, and age groups globally, including various underserved populations including migrant populations. There was general alignment with most of the 2022 WHO Guide priority action areas across both COVID-19 and other vaccine studies, pointing to ongoing understandings of the importance of administratively accessible and culturally/linguistically appropriate models of vaccine delivery for refugee and migrant populations. Increasingly dominant approaches in the COVID-19 pandemic include multipronged strategies with wide community and multisectoral collaborations to co-design strategies addressing barriers. Additionally, COVID-19 vaccination models increasingly utilized innovative social media and customization strategies, including targeted communication campaigns responsive to misinformation. Although there are increased calls for the use of data to design and evaluate interventions, notable gaps remain in the collection, use and reporting of data used to conduct interventions.

conclusionsFindings summarize vaccination models of delivery for COVID-19 and other vaccines for diverse refugee and migrant populations globally. Healthcare professionals, policy makers, and vaccination campaign planners can draw and build from strategies employed in other settings as aligned with WHO priority actions to increase equitable access to vaccines for refugee and migrant communities. Further collection and use of disaggregated and real-time data to inform and evaluate customized strategies for specific migrant groups is recommended to improve understandings of equitable vaccine delivery models.

Indexed as

COVID-19COVID-19 VaccinesRefugeesTransients and MigrantsVaccinationGlobal HealthHumansSARS-CoV-2COVID-19 VaccinesCOVID-19MigrantsRefugeesVaccinationVaccination barriersVaccine delivery

Identifiers

PMID41063068
PMCPMC12505711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.